We are live on ! Find out more
GWCM

Godshalk Welsh Capital Management Portfolio holdings

AUM $172M
1-Year Est. Return 16.03%
This Fund
S&P 500
This Quarter Est. Return
-4.37%
1 Year Est. Return
+16.03%
3 Year Est. Return
+54.69%
5 Year Est. Return
+73.83%
10 Year Est. Return
+285.54%
AUM
$135M
AUM Growth
-$3.81M
Cap. Flow
+$4.01M
Cap. Flow %
2.96%
Top 10 Hldgs %
29.44%
Holding
123
New
8
Increased
72
Reduced
25
Closed
6

Top Buys

Rank Stock Value
1
GMED icon
Globus Medical
GMED
+$1.5M
2
GLW icon
Corning
GLW
+$390K
3
UL icon
Unilever
UL
+$274K
4
UBER icon
Uber
UBER
+$262K
5
SCHD icon
Schwab US Dividend Equity ETF
SCHD
+$251K

Sector Composition

Rank Sector Weight
1 Technology 20.12%
2 Healthcare 15.42%
3 Consumer Staples 11.38%
4 Financials 10.77%
5 Consumer Discretionary 6.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LMT icon
76
Lockheed Martin
LMT
$138B
$495K 0.37%
1,282
+7
+0.5% +$2.92K
UL icon
77
Unilever
UL
$133B
$467K 0.34%
9,461
+5,239
+124% +$274K
ED icon
78
Consolidated Edison
ED
$39.9B
$463K 0.34%
5,400
AOM icon
79
iShares Core Moderate Allocation ETF
AOM
$1.77B
$456K 0.34%
12,456
+1,890
+18% +$74K
INTC icon
80
Intel
INTC
$507B
$452K 0.33%
17,524
-3,025
-15% -$103K
EEMV icon
81
iShares MSCI Emerging Markets Min Vol Factor ETF
EEMV
$3.59B
$449K 0.33%
8,850
+500
+6% +$27.3K
QQQ icon
82
Invesco QQQ Trust
QQQ
$481B
$447K 0.33%
1,672
DGX icon
83
Quest Diagnostics
DGX
$26.3B
$445K 0.33%
3,625
-25
-0.7% -$3.29K
BMY icon
84
Bristol-Myers Squibb
BMY
$130B
$422K 0.31%
5,930
+380
+7% +$27.6K
IUSG icon
85
iShares Core S&P US Growth ETF
IUSG
$33.7B
$417K 0.31%
5,196
+701
+16% +$63.1K
DHR icon
86
Danaher
DHR
$145B
$407K 0.3%
1,777
-28
-2% -$6.86K
DD icon
87
DuPont de Nemours
DD
$19.2B
$392K 0.29%
6,200
+201
+3% +$14.3K
CLX icon
88
Clorox
CLX
$12.9B
$363K 0.27%
2,825
-32
-1% -$4.62K
ABT icon
89
Abbott
ABT
$191B
$347K 0.26%
3,582
+25
+0.7% +$2.67K
MAS icon
90
Masco
MAS
$14.7B
$339K 0.25%
7,250
-50
-0.7% -$2.6K
GLW icon
91
Corning
GLW
$143B
$334K 0.25%
+11,525
New +$390K
RSG icon
92
Republic Services
RSG
$66.5B
$320K 0.24%
2,350
MMM icon
93
3M
MMM
$94.4B
$294K 0.22%
3,181
+239
+8% +$26.2K
AOR icon
94
iShares Core 60/40 Balanced Allocation ETF
AOR
$3.74B
$285K 0.21%
6,363
+643
+11% +$31.1K
UGI icon
95
UGI
UGI
$7.5B
$284K 0.21%
8,775
-1,550
-15% -$61.2K
IGSB icon
96
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$23.3B
$277K 0.2%
5,617
+107
+2% +$5.4K
SO icon
97
Southern Company
SO
$106B
$274K 0.2%
4,035
UNP icon
98
Union Pacific
UNP
$174B
$258K 0.19%
1,322
+22
+2% +$4.87K
KO icon
99
Coca-Cola
KO
$375B
$254K 0.19%
4,536
+436
+11% +$27.1K
UBER icon
100
Uber
UBER
$154B
$251K 0.19%
+9,485
New +$262K

Similar funds

Godshalk Welsh Capital Management's Q3 2022 Portfolio in Review

As of Q3 2022, Godshalk Welsh Capital Management held 123 positions worth $135M, down 2.7% from $139M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Godshalk Welsh Capital Management's Q3 2022 filing shows 8 new, 72 increased, 25 reduced and 6 closed positions. Its largest new stake was Corning: 11,525 shares worth $334K. The largest sale was Vanguard Intermediate-Term Bond ETF, an estimated $836K.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Staples.

  • Godshalk Welsh Capital Management's largest Q3 2022 buy was Corning: 11,525 shares worth $334K.
  • Godshalk Welsh Capital Management added most to Globus Medical in Q3 2022, an estimated $1.5M increase.
  • Godshalk Welsh Capital Management's biggest Q3 2022 reduction was Vanguard Intermediate-Term Bond ETF, cutting an estimated $836K.
  • Godshalk Welsh Capital Management fully exited Organon & Co in Q3 2022, selling an estimated $744K.
  • Godshalk Welsh Capital Management's ten largest holdings make up 29% of its $135M portfolio in Q3 2022.
  • Godshalk Welsh Capital Management opened 8 new positions and closed 6 in Q3 2022.
  • Godshalk Welsh Capital Management's portfolio value fell 2.7% quarter-over-quarter to $135M.

Based on Godshalk Welsh Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.